STOCKWATCH
·
Medical Specialities
Quarterly ResultApr 28, 2026, 06:12 AM

CENTENE Q1 Revenue $49.94B, Adj. EPS $3.37; Net Earnings $1.54B

AI Summary

Centene Corp reported Q1 2026 total revenues of $49.94 billion, an increase from $46.62 billion in Q1 2025. GAAP net earnings attributable to Centene rose to $1.54 billion ($3.11 diluted EPS), while adjusted net earnings reached $1.67 billion ($3.37 adjusted diluted EPS). The company also entered a definitive agreement to sell the remaining Magellan Health businesses and sold $1 billion of 2025 Part D risk-sharing program receivables.

Key Highlights

  • Q1 2026 Total Revenues: $49.94B, up from $46.62B in Q1 2025.
  • Q1 2026 GAAP Net Earnings: $1.54B, up from $1.31B in Q1 2025.
  • Q1 2026 Adjusted Diluted EPS: $3.37, up from $2.90 in Q1 2025.
  • Net cash provided by operating activities: $4.37B, up from $1.51B in Q1 2025.
  • Signed definitive agreement to sell remaining Magellan Health businesses.
  • Sold $1B of 2025 Part D receivables for $970M, incurring $30M loss.
  • Repurchased $29 million in common stock during Q1 2026.
CNC
Medical Specialities
CENTENE CORP

Price Impact